As of 31 Dec 2025, 11 institutional investors reported holding 1,660,905 shares of ROCKET PHARMACEUTICALS, INC. - *W EXP 09/02/202 (RCKTW).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1,660,905 | $165,102 | -$8,906 | $0.02 | 11 |
| 2025 Q3 | 2,003,857 | $195,096 | -$4,266 | $0.04 | 11 |
| 2025 Q2 | 2,112,110 | $161,071 | -$5,849 | $0.03 | 11 |
| 2025 Q1 | 2,217,523 | $102,669 | +$5,419 | $0.05 | 12 |
| 2024 Q4 | 2,141,809 | $537,904 | -$78,905 | $0.03 | 10 |
| 2024 Q3 | 3,223,277 | $903,887 | -$11,140 | $0.07 | 14 |
| 2024 Q2 | 3,390,491 | $1,002,631 | -$60,105 | $0.06 | 14 |
| 2024 Q1 | 3,413,888 | $1,011,637 | +$237,436 | $0.30 | 15 |
| 2023 Q4 | 2,643,608 | $1,271,387 | -$56,131 | $0.49 | 14 |
| 2023 Q3 | 2,784,216 | $1,216,289 | -$4,237,800 | $0.17 | 17 |
| 2023 Q2 | 3,485,520 | $5,389,105 | +$4,766,115 | $0.19 | 17 |
| 2023 Q1 | 2,110,267 | $332,083 | +$332,083 | $0.16 | 11 |